Lymphoma pseudoprogression observed on [18F]FDG PET-CT scan 15 days after CAR-T infusion.

Authors :: Cohen, Dan
Beyar-Katz, Ofrat
Even-Sapir, Einat
Perry, Chava
Source :: European Journal of Nuclear Medicine & Molecular Imaging. Jun2022, Vol. 49 Issue 7, p2447-2449. 3p. 1 Diagram.
Publication Year :: 2022
Abstract: The article reports that A 23-year-old female with refractory diffuse large B-cell lymphoma was referred to chimeric antigen receptor T-cell (CAR-T) therapy (axicabtagene ciloleucel). Before infusion, FDG PET-CT (A) identified active supra-diaphragmatic nodal and hepatic disease (SUVmax 14.5). Nine days following infusion, enlarged cervical masses were palpated and the patient complained of worsening dyspnea.

Subjects :: *BCL-2 proteins
*T-cell lymphoma
*INFUSION therapy
*LIVER cells
*DYSPNEA

Full Text Access

Tools